PROSTATE-SPECIFIC ANTIGEN AS A SCREENING TEST : The Netherlands Experience - 11/09/11

Doi : 10.1016/S0094-0143(05)70377-3

Chris H. Bangma, MD, PhD ^{^{*
From the Department of Urology, Erasmus University and Academic Hospital, Rotterdam, The Netherlands}}, John B.W. Rietbergen, MD ^{^{*
From the Department of Urology, Erasmus University and Academic Hospital, Rotterdam, The Netherlands}}, Fritz H. Schröder, MD, PhD ^{^{*
From the Department of Urology, Erasmus University and Academic Hospital, Rotterdam, The Netherlands}}

Mappa

INDICATIONS FOR BIOPSY

PSA CUT-OFF VALUE

THE NATURE OF PSA SCREEN-DETECTED CARCINOMAS

INCREASING THE SPECIFICITY OF PSA

SUMMARY

Address reprint requests to Chris H. Bangma, MD, PhD, Department of Urology, Erasmus University and, Academic Hospital Rotterdam, Dr Molenwaterplein 40, 3015 GD Rotterdam, The Netherlands
These studies are supported by grants from “Europe against Cancer,” the Dutch Cancer Society (KWF), and the Prevention Fund of the Netherlands as well as by an educational grant of Wallac Oy, Finland.

Esportazione

Vol 24 - N° 2

P. 307-314 - maggio 1997 Ritorno al numero

Articolo precedente

PROSTATE-SPECIFIC ANTIGEN AS A SCREENING TEST FOR PROSTATE CANCER : The United States Experience
Carlos G. Arcangeli, David K. Ornstein, David W. Keetch, Gerald L. Andriole

| Articolo seguente

PROSTATE-SPECIFIC ANTIGEN AS A SCREENING TEST : The Austrian Experience
Andreas Reissigl, Georg Bartsch

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

PROSTATE-SPECIFIC ANTIGEN AS A SCREENING TEST : The Netherlands Experience - 11/09/11

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL